Green Nanotechnology: Golden Approach to Treating Liver Cancer

Green technology using gold nanoparticles could be the golden ticket to treating liver cancer. At University of Missouri School of Medicine, researchers prove that a new minimally invasive approach targets and destroys precancerous tumor cells in the livers of mice and in-vitro human cells. Researchers are using gold nanoparticles encapsulated by a protective stabilizer called gum Arabic. It promotes the bonding of gold nanoparticles that are engineered to attract precancerous and malignant cells. They travel and attach themselves to cancerous cells. Then they are heated to a temperature that destroys cancer cells through a process known as photothermal therapy.

This series explores the latest science and technology news in the St. Louis area.

Green Nanotechnology: Golden Approach to Treating Liver Cancer

Tags |
Recent Segment | Innovations

The World's Largest 3D Printed Object for 777X Airplane at Boeing

The 777X wing trim and drill tool is now the world’s “largest solid 3-D printed item,” certified by Guinness World Records

Recent Segment | Innovations

Video Game Technology Helping Physical Therapy Patients & Athletes at Mizzou Lab

Mizzou researchers are using the depth camera associated with video game systems to help physical therapy patients and athletes.

Recent Segment | Innovations

New Software for Drug Companies to Make Drugs Cheaper, Faster and Better

New software will provide pharmaceutical companies the ability to develop drugs cheaper, faster and better by improving calculations of drug-target binding.

Recent Segment | Innovations

Scopio Finds Images on Social Media, Letting Users Get Paid for Their Photos

A company with roots in St.Louis is finding ways to sift through social media to find marketable photos. From there, they put brands and photographers together.

Episodes

There are 139 more episodes of Innovations.

Recent Segment | Innovations

New Method of Protection Against Pneumococcal Pneumonia

VaxNewMo has engineered E. coli to manufacture pneumococcal conjugate vaccines.

Register Now

Attend a live taping of this episode by filling out the form below.

Date: April 18, 2015 Time: 10:00am